EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis

Gabriel Bsteh iD, Ruchi Tanavade, Nik Krajnc iD, Fabian Föttinger, Theresa König, Martin Krenn iD, Lukas Haider, Barbara Kornek iD, Fritz Leutmezer, Kerstin U Ludwig, Stefan Macher iD, Tobias Monschein und 11 weitere

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.70157 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Gabriel Bsteh und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Retina, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Austrian MS Research Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate whether the rs10191329 risk allele in the DYSF–ZNF638 locus, which is implicated in central nervous system resilience rather than immune‐mediated pathology, is associated with retinal layer thinning, a biomarker of neuroaxonal damage in relapsing multiple sclerosis (RMS).

Methods

From a prospective observational study, we included RMS patients with ≥ 2 optical coherence tomography (OCT) scans, excluding eyes with optic neuritis during the observation period. DNA samples were genotyped using the Illumina Infinium Global Screening Array‐24 and variants imputed using the Haplotype Reference Consortium panel and Minimac4. Multivariable linear regression models were used to assess the association between rs10191329 risk allele number (rs10191329*A) and annualized rates of peripapillary retinal nerve fiber layer (aLpRNFL) and macular ganglion‐cell‐and‐inner‐plexiform‐layer (aLGCIPL) atrophy, adjusting for age, sex, MS‐specific variables, and 10 ancestry components.

Results

We included 183 RMS patients (mean age 35.9 years [SD 9.6], 74.9% female, median EDSS 2.0 [range 0–6.5], median observation 25 months [12–73], median OCT scans 3 [2–5]). Multivariable analyses revealed that each rs10191329*A allele was associated with a 0.10%/year increase in aLpRNFL (95% confidence interval [CI] 0.05–0.19, p < 0.001) and a 0.11%/year increase in aLGCIPL (95% CI 0.07–0.19, p < 0.001). The rs10191329 variant explained 8.9% of GCIPL atrophy and 8.2% of pRNFL atrophy variance.

Interpretation

Carriers of the rs10191329 risk allele show accelerated retinal atrophy, suggesting heightened neuroaxonal vulnerability in MS. While clinical implications are currently unclear, genetic stratification may be reasonable in clinical trials targeting neuroprotection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinaMultiple Sclerosis, Relapsing-RemittingMultiple SclerosisHumansFemaleMaleAdultTomography, Optical CoherenceAtrophyMiddle AgedProspective StudiesAllelesPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

biomarkergeneticmultiple sclerosisoptical coherence tomographypredictorrs10191329

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
  • Institute of Human Genetics, School of Medicine, University Bonn & University Hospital Bonn, Bonn, Germany.
  • Department of Neuroradiology, Medical University of Vienna, Vienna, Austria.
  • Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

ORCID-Profile: Gabriel Bsteh, Nik Krajnc, Martin Krenn, Barbara Kornek, Stefan Macher, Tobias Zrzavy, Berthold Pemp

Förderung

  • Austrian MS Research Society

Zitieren

APA

Bsteh, G., Tanavade, R., Krajnc, N., Föttinger, F., König, T., Krenn, M., Haider, L., Kornek, B., Leutmezer, F., Ludwig, K. U., Macher, S., Monschein, T., Ponleitner, M., Rommer, P., Schmied, C., Zebenholzer, K., Zrzavy, T., Zulehner, G., Di Pauli, F., …, & Berger, T. (2025). The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70157

Vancouver

Bsteh G, Tanavade R, Krajnc N, Föttinger F, König T, Krenn M, et al. The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70157

BibTeX
@article{Bsteh2025,
  author = {Bsteh, Gabriel and Tanavade, Ruchi and Krajnc, Nik and Föttinger, Fabian and König, Theresa and Krenn, Martin and Haider, Lukas and Kornek, Barbara and Leutmezer, Fritz and Ludwig, Kerstin U and Macher, Stefan and Monschein, Tobias and Ponleitner, Markus and Rommer, Paulus and Schmied, Christiane and Zebenholzer, Karin and Zrzavy, Tobias and Zulehner, Gudrun and Di Pauli, Franziska and Schmidt, Axel and Hegen, Harald and Pemp, Berthold and Berger, Thomas},
  title = {The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.70157}
}
Kostenlos starten →